Search research articles
Contact Us
Filters
Showing results (51-60 of 106) with videos related to
Page
of 11
Sort By:
Radiation Research
|
May 1, 1997
Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields
M H Repacholi, A Basten, V Gebski, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 1, 1997
Does waiting time affect the outcome of larynx cancer treated by radiotherapy?
M B Barton, G Morgan, R Smee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1993
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer
P G Gill, V Gebski, R Snyder, et al.
The Medical Journal of Australia
|
February 18, 1985
Menstruation, menstrual protection and menstrual cycle problems. The knowledge, attitudes and practices of young Australian women
S Abraham, I Fraser, V Gebski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1992
Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group
A Coates, V Gebski, D Signorini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2002
Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer
B Gray, G Van Hazel, M Hope, et al.
Contemporary Clinical Trials
|
July 8, 2014
Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial
A L Hawkes, M Quinn, V Gebski, et al.
Australasian Radiology
|
September 20, 2006
Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial
M J Veness, F Foroudi, V Gebski, et al.
British Journal of Cancer
|
June 20, 2013
Markers of systemic inflammation predict survival in patients with advanced renal cell cancer
P Fox, M Hudson, C Brown, et al.
Pathology
|
July 10, 1999
The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting
S W Wong, A M Rangan, A M Bilous, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 106) with videos related to
Sort By:
Page
of 11
Radiation Research
|
May 1, 1997
Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields
M H Repacholi, A Basten, V Gebski, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 1, 1997
Does waiting time affect the outcome of larynx cancer treated by radiotherapy?
M B Barton, G Morgan, R Smee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1993
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer
P G Gill, V Gebski, R Snyder, et al.
The Medical Journal of Australia
|
February 18, 1985
Menstruation, menstrual protection and menstrual cycle problems. The knowledge, attitudes and practices of young Australian women
S Abraham, I Fraser, V Gebski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1992
Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group
A Coates, V Gebski, D Signorini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2002
Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer
B Gray, G Van Hazel, M Hope, et al.
Contemporary Clinical Trials
|
July 8, 2014
Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial
A L Hawkes, M Quinn, V Gebski, et al.
Australasian Radiology
|
September 20, 2006
Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial
M J Veness, F Foroudi, V Gebski, et al.
British Journal of Cancer
|
June 20, 2013
Markers of systemic inflammation predict survival in patients with advanced renal cell cancer
P Fox, M Hudson, C Brown, et al.
Pathology
|
July 10, 1999
The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting
S W Wong, A M Rangan, A M Bilous, et al.
Page
of 11